Cyclerion Therapeutics (CYCN) Current Assets (2019 - 2025)
Historic Current Assets for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to $5.1 million.
- Cyclerion Therapeutics' Current Assets rose 4275.65% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year increase of 4275.65%. This contributed to the annual value of $4.2 million for FY2024, which is 4734.55% down from last year.
- Per Cyclerion Therapeutics' latest filing, its Current Assets stood at $5.1 million for Q3 2025, which was up 4275.65% from $4.0 million recorded in Q2 2025.
- Cyclerion Therapeutics' Current Assets' 5-year high stood at $73.0 million during Q2 2021, with a 5-year trough of $3.5 million in Q3 2024.
- Over the past 5 years, Cyclerion Therapeutics' median Current Assets value was $8.3 million (recorded in 2023), while the average stood at $21.7 million.
- Its Current Assets has fluctuated over the past 5 years, first plummeted by 8054.21% in 2023, then soared by 4275.65% in 2025.
- Cyclerion Therapeutics' Current Assets (Quarter) stood at $55.5 million in 2021, then plummeted by 73.28% to $14.8 million in 2022, then plummeted by 45.86% to $8.0 million in 2023, then plummeted by 47.35% to $4.2 million in 2024, then increased by 19.88% to $5.1 million in 2025.
- Its last three reported values are $5.1 million in Q3 2025, $4.0 million for Q2 2025, and $4.5 million during Q1 2025.